![](https://www.pahc.com/wp-content/uploads/2021/08/MB-1_logo_CMYK_R-e1639153302104.png)
An Evolution in IBD Hatchery Vaccination
MB-1® live attenuated vaccine for Infectious Bursal Disease, was developed from the M.B. strain, adapted for in-ovo or subcutaneous injection in the hatchery.
![](https://www.pahc.com/wp-content/uploads/MB-1-1.png)
Efficacy
The MB-1 vaccine provides, on average, 4-day earlier onset of immunity compared to other hatchery vaccines.
Convenience
The MB-1 vaccine adjusts its release to the individual titer of IBD Maternally Derived Antibodies generating the desired immune response in every chick at the optimal time.
Safety
The MB-1 vaccine is safe and does not interfere with the immune response to other vaccines.
![](https://www.pahc.com/wp-content/uploads/2021/08/rounded-play-button-white.png)
Why do we vaccinate against Gumboro disease (IBD)?
Juan Carlos Valladares
Poultry Vaccines Technical Manager
![](https://www.pahc.com/wp-content/uploads/2021/08/rounded-play-button-white.png)
What is the role of MDAs in early
protection against IBD - especially
when using hatchery vaccination?
Charles Costello
Poultry Technical and Marketing Director
MB-1 Mode of Action
How does MB-1 differ from other IBD vaccines?